We previously described a small group of renal transplant recipients consid
ered to have successful allografts statistically but who did not benefit cl
inically. These were patients in whom the grafts survived greater than 6 mo
nths but less than 3 years. This expanded study evaluates 179 consecutive r
enal transplant recipients divided into three groups. Group 1 (n = 18), gro
up 2 (n = 41), and group 3 (n = 120) have patients with graft survival less
than 6 months, between 6 months and 3 years, and greater than 3 years, res
pectively. Mean age, cause of renal failure, HLA match, and immunosuppressi
ve regimen were not statistically different in any group. The number of acu
te rejection episodes, number of hospitalizations, and number and seriousne
ss of complications were significantly greater in group 2 patients compared
with the other groups. Patients in group 2 experienced five times the numb
er of acute rejections (P < 0.0001), three times the number of hospitalizat
ions (P < 0.0001), and two times the number of complications (P < 0.0001) c
ompared with group 3 patients. In conclusion, those transplant recipients w
hose grafts survived longer than 6 months but less than 3 years were the mo
st unfortunate. They experienced repeated and serious complications and spe
nt many days in the hospital at great expense. A study with more sensitive
methods of detecting presensitization might impact on graft performance in
the future. (C) 1999 by the National Kidney Foundation, Inc.